Our Sales Cycle Is Too Long
in Insurance Brokers

The short answer

Long cycles are usually the buyer failing to build an internal case for the CFO on commission structure and renewal retention, not the broker failing to explain coverage. Insurance brokers carry a specific bind here — 71 percent of revenue flows through carrier commissions while shifting an incremental 8 percent to fees would require replacing 142 renewal accounts and cut near-term margin by 1.8 to 2.3 points. Until that is priced, 19.0 will keep moving for reasons nobody can attribute, and the debate about stage duration will stay a matter of opinion.

A cycle that runs long is rarely stalled on interest in the placement. It is stalled at a specific point — a stage where the deal consistently sits — and that point is normally where the broker has to justify the decision to the CFO on how the move affects the 71 percent of revenue from carrier commissions versus the margin impact of shifting to fees.

Which reframes the fix. Shortening a cycle is mostly a matter of giving the champion the material to win an argument the broker is not present for: the comparison of standard commissions against contingent commissions, the risk-control analysis, or the captive feasibility numbers that show why the current structure costs more than doing nothing.

The other frequent cause is selling to someone who cannot authorise the spend. That does not lengthen the cycle so much as add a hidden one at the end when the file reaches the CFO who controls the 47.8 million dollars in total revenue from commissions and fees.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ Renewal retention numbers slip on the same accounts quarter after quarter
✓ Projected contingent commissions and standard commissions fall short on the same opportunities
✓ Lost placements are replaced by no decision rather than a competing broker

The move that usually makes it worse. Adding follow-up activity, which increases pressure on the champion without giving them anything new to take to the CFO.

Who this is for — and who it is not

It is for you if you run or finance an insurance broker and deals consistently stall at the same stage. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on an insurance broker. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Kesterline Risk Partners, a sample company profile used for testing rather than a customer — 47.8 million dollars in total revenue from commissions and fees.

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For insurance brokers it works through 19.0, 91.2, 664 and 31, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

How do I speed up a long sales cycle?

Find the stage where deals sit longest and work out what the buyer has to do there. It is almost always an internal approval, and the fix is material rather than persuasion.

Should I discount to close faster?

It compresses the last step and does nothing to the stalls earlier in the cycle, which is where the time actually goes. It also teaches buyers that waiting is rewarded.

Is a long cycle always a problem?

No, if the deal size and win rate justify it. It becomes a problem when the cycle is longer than your cash conversion allows, which is a financing constraint rather than a sales one.

Is this different in insurance brokers than in other industries?

Materially, yes. 71 percent of revenue flows through carrier commissions while shifting an incremental 8 percent to fees would require replacing 142 renewal accounts and cut near-term margin by 1.8 to 2.3 points — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 19.0, 91.2, 664, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for an insurance broker?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 19.0 and 91.2. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.